What are the causes of uremia (azotemia), a condition characterized by impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025 • View editorial policy

From the Guidelines

Uremia is primarily caused by kidney failure, which can result from acute kidney injury (AKI) or chronic kidney disease (CKD), with the latter being a more common cause of uremia in the long term. The main causes of kidney failure leading to uremia include CKD, which can result from conditions like diabetes, hypertension, glomerulonephritis, polycystic kidney disease, and recurrent kidney infections 1. AKI, on the other hand, can cause uremia due to severe dehydration, blood loss, sepsis, certain medications, contrast dyes used in imaging studies, and urinary tract obstructions such as kidney stones or enlarged prostate. Some key points to consider in the causes of uremia include:

  • Prerenal factors, such as impaired blood flow from any cause including hypotension, hypovolemia, decreased cardiac output, or renal artery occlusion, can contribute to AKI and subsequently uremia 1.
  • Renal causes, including any disease that damages renal parenchyma, such as vasculitis, acute tubular necrosis, glomerulonephritis, interstitial nephritis, renal infection or infiltration, drugs, and toxins, are also significant contributors to AKI and uremia 1.
  • Postrenal AKI, resulting from ureteral, bladder, or urethral obstruction, is less common but can also lead to uremia 1. Uremia develops when kidney function declines to the point where waste products like urea, creatinine, and other nitrogenous compounds accumulate in the bloodstream, leading to symptoms such as nausea, fatigue, confusion, itching, and in severe cases, seizures or coma. Treatment typically involves addressing the underlying cause, managing complications, and in advanced cases, renal replacement therapy such as dialysis or kidney transplantation, with the goal of improving morbidity, mortality, and quality of life for patients with uremia.

From the Research

Causes of Uremia

  • Uremia is a chemical, toxic, potentially fatal condition that can be produced by hundreds of diseases, both kidney and systemic (e.g., diabetes) 2.
  • The condition ultimately kills almost every cell in the body and can range from acute and catastrophic to slowly and moderately progressive 2.
  • Uremia is associated with end-stage renal disease (ESRD), which affects approximately 745,000 individuals in the United States 3.
  • ESRD is diagnosed when kidney function is no longer adequate for long-term survival without kidney transplantation or dialysis 4.
  • Hyperkalemia, hypervolemia, metabolic acidosis, anemia, mineral and bone disorders, and protein-calorie malnutrition are common complications of ESRD 3.
  • Pain, nonpain symptoms, and fatigue are also common in patients with ESRD and can affect quality of life 5.
  • Uremia-associated nausea and pruritus can be managed with medications such as ondansetron, naltrexone, and phosphate binders 5.

Treatment Options

  • Dialysis, including peritoneal dialysis and hemodialysis, and kidney transplantation are available treatment options for patients with ESRD 6, 4, 3.
  • Palliative care and hospice referral are indicated for patients who decide against renal replacement therapy or choose to discontinue dialysis 3, 5.

References

Guideline

acr appropriateness criteria® renal failure.

Journal of the American College of Radiology, 2021

Research

How end-stage renal disease (ESRD)-medicare developed.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000

Research

End-Stage Renal Disease: Medical Management.

American family physician, 2021

Research

[Dialysis in end-stage kidney disease].

Nederlands tijdschrift voor geneeskunde, 2020

Related Questions

What are the treatment options for gustatory sweating in a 60-year-old patient with end-stage renal disease (ESRD) on chronic dialysis?
What is the treatment for nausea in patients with End-Stage Renal Disease (ESRD)?
What are the appropriate laboratory tests and treatment for a patient with severe back and shoulder pain, who experienced relief with Tylenol (acetaminophen), presents with a low-grade fever, and has a history of End-Stage Renal Disease (ESRD) on dialysis?
What are the causes of hyperammonemia in End-Stage Renal Disease (ESRD)?
Can End-Stage Renal Disease (ESRD) patients take Harding (unknown medication, please specify generic name)?
Is it advisable to take blood pressure on the same side as a lumpectomy (surgical removal of a lump, typically from the breast)?
What is the most appropriate management for a 73-year-old woman with stage G4 chronic kidney disease (Chronic Kidney Disease, CKD), hypertension, and secondary hyperparathyroidism, with laboratory results showing hyperphosphatemia, normal calcium levels, and elevated parathyroid hormone (PTH) levels, while on medications including atenolol, chlorthalidone, cholecalciferol (Vitamin D3), hydralazine, and nifedipine (Calcium Channel Blocker)?
Can I use Colesevelam (Welchol) with a statin (HMG-CoA reductase inhibitor)?
Is urinary incontinence common in patients with syncope (fainting)?
What drugs cause uremia (azotemia, impaired renal function)?
What is the most appropriate management for a patient with hyponatremia (serum sodium level of 130 milliequivalents per liter (mEq/L)) and symptoms of headache, confusion, and disorientation after participating in a marathon?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.